Edwards Lifesciences Belgium SRL

29.0 FTE

Edwards Lifesciences Belgium reported revenue of €14.0m for the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026), with 29 full-time equivalents.

By total assets for 2025, Edwards Lifesciences Belgium ranks among the 50 largest of the 684 companies in its sector (NACE 3250) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0469.903.830 · VAT BE0469903830
1800 Vilvoorde
active in Manufacture of medical and dental instruments and supplies (NACE 32500)
operating since 19 Jan 2000 (≈ 26 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Edwards Lifesciences Belgium shows with a free account.

See the score
Profile
SRL Small · 29.0 FTE since 2000
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€14.0m
Net result573,081 €
Equity€5.27m
EBITDA968,500 €
Total assets€9.83m
Headcount (avg FTE)29.0
The line marks its sector median: 51.2% (372 companies).

Change 2022 → 2025: Revenue -23 % Equity +72 % Total assets +6 % Headcount (avg FTE) -25 %

Accounts of the company itself (not consolidated).

The full file covers 11 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Edwards Lifesciences Belgium's annual accounts

20252024202320222021
Revenue€14.0m
Net result573,081 €
Equity€5.27m
EBITDA968,500 €
Total assets€9.83m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 16 Jul 2026
  • Year ended 31 Dec 2024filed on 25 Jul 2025
  • Year ended 31 Dec 2023filed on 22 May 2024
  • Year ended 31 Dec 2022filed on 10 Jul 2023
  • Year ended 31 Dec 2021filed on 22 Nov 2022

Edwards Lifesciences Belgium's financial analysis

Management and control of Edwards Lifesciences Belgium

3 active director(s) in the register.

Edwards Lifesciences Belgium's shareholders and holdings →

Edwards Lifesciences Belgium's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0469.903.830
VAT number
BE0469903830
Peppol
Registered · 0208:0469903830 · as of 14 Nov 2026
Legal form
SRL
Incorporated
19 Jan 2000
Registered office
1800 Vilvoorde
Size
Small · 29.0 FTE
Latest accounts
2025 · filed on 16 Jul 2026
Activity
Manufacture of medical and dental instruments and supplies (NACE 32500)

Edwards Lifesciences Belgium (SRL) has been based in Vilvoorde since 2000, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports revenue of €14.0m, a net profit of 573,081 € and equity of €5.27m. With 29.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 53.6%, above the median of its sector (51.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Edwards Lifesciences Belgium

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Edwards Lifesciences Belgium

What is the revenue of Edwards Lifesciences Belgium?

According to the 2025 annual accounts filed with the NBB, the revenue of Edwards Lifesciences Belgium amounts to 13,957,832 €.

What is the VAT number of Edwards Lifesciences Belgium?

In Belgium, the VAT number is the company number prefixed with BE: BE0469903830 for Edwards Lifesciences Belgium, if the company is VAT-registered. Its company number (CBE) is 0469.903.830.

Where is the registered office of Edwards Lifesciences Belgium?

According to the CBE register, the registered office of Edwards Lifesciences Belgium is in 1800 Vilvoorde.

What is the equity of Edwards Lifesciences Belgium?

At the close of the 2025 financial year, the equity of Edwards Lifesciences Belgium amounts to 5,274,461 €, a solvency of 53.6% of total assets.

How many people work at Edwards Lifesciences Belgium?

29.0 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Edwards Lifesciences Belgium?

The register lists 3 active mandates at Edwards Lifesciences Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Edwards Lifesciences Belgium within its sector?

By total assets for 2025, Edwards Lifesciences Belgium ranks among the 50 largest of the 684 companies in its sector (NACE 3250) in Belgium that filed accounts for that financial year.

Idonis

The full file of Edwards Lifesciences Belgium

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 12 Aug 2026

No credit card, no commitment.

What each plan unlocks →